Skip to content

Cumberland Pharmaceuticals Inc.: 10-K filed 2022-03-11

What Cumberland Pharmaceuticals Inc. reported in its annual report filed 2022-03-11 (fiscal FY 2021): 52 published measures, 175 facts as tagged in accession 0001628280-22-005942.

This filing

Form
10-K (annual report)
Filed
2022-03-11
Fiscal period
fiscal FY 2021
Accession
0001628280-22-005942 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cumberland Pharmaceuticals Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-12-3184,459,798USD
At 2020-12-3196,463,305USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-12-3141,857,820USD
At 2020-12-3149,589,911USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-12-3142,814,306USD
At 2020-12-3146,990,510USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-12-3127,040,816USD
At 2020-12-3124,753,796USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-3,847,697USD92
2021-01-01 to 2021-12-31-3,507,587USD365
2021-07-01 to 2021-09-30-1,055,278USD92
2021-04-01 to 2021-06-301,228,560USD91
2021-01-01 to 2021-03-31166,828USD90
2020-10-01 to 2020-12-31-883,776USD92
2020-01-01 to 2020-12-31-3,339,408USD366
2020-07-01 to 2020-09-30-481,737USD92
2020-04-01 to 2020-06-30-918,275USD91
2020-01-01 to 2020-03-31-1,055,620USD91
2019-01-01 to 2019-12-31-3,537,759USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-12-316,342,443USD365
2020-01-01 to 2020-12-315,415,061USD366
2019-01-01 to 2019-12-313,056,356USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-12-31103,532USD365
2020-01-01 to 2020-12-31140,817USD366
2019-01-01 to 2019-12-31246,202USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-10-01 to 2021-12-318,319,861USD92
2021-01-01 to 2021-12-3135,985,043USD365
2021-07-01 to 2021-09-308,072,540USD92
2021-04-01 to 2021-06-309,055,483USD91
2021-01-01 to 2021-03-3110,537,159USD90
2020-10-01 to 2020-12-3110,261,534USD92
2020-01-01 to 2020-12-3137,441,134USD366
2020-07-01 to 2020-09-309,250,689USD92
2020-04-01 to 2020-06-309,598,177USD91
2020-01-01 to 2020-03-318,330,734USD91
2019-01-01 to 2019-12-3134,388,295USD365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-01-01 to 2021-12-3135,045,259USD365
2020-01-01 to 2020-12-3135,840,673USD366
2019-01-01 to 2019-12-3132,407,845USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-3,553,530USD365
2020-01-01 to 2020-12-31-7,116,111USD366
2019-01-01 to 2019-12-31-5,080,529USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-501,893USD365
2020-01-01 to 2020-12-31-1,757,789USD366
2019-01-01 to 2019-12-312,297,848USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-12-31-5,638,600USD
At 2020-12-31-2,131,013USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-01-01 to 2021-12-3114,904,834shares365
2020-01-01 to 2020-12-3115,162,184shares366
2019-01-01 to 2019-12-3115,396,098shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-01-01 to 2021-12-3114,904,834shares365
2020-01-01 to 2020-12-3115,162,184shares366
2019-01-01 to 2019-12-3115,396,098shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-0.26USD/shares92
2021-01-01 to 2021-12-31-0.24USD/shares365
2021-07-01 to 2021-09-30-0.07USD/shares92
2021-04-01 to 2021-06-300.08USD/shares91
2021-01-01 to 2021-03-310.01USD/shares90
2020-10-01 to 2020-12-31-0.06USD/shares92
2020-01-01 to 2020-12-31-0.22USD/shares366
2020-07-01 to 2020-09-30-0.03USD/shares92
2020-04-01 to 2020-06-30-0.06USD/shares91
2020-01-01 to 2020-03-31-0.07USD/shares91
2019-01-01 to 2019-12-31-0.23USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-0.26USD/shares92
2021-01-01 to 2021-12-31-0.24USD/shares365
2021-07-01 to 2021-09-30-0.07USD/shares92
2021-04-01 to 2021-06-300.08USD/shares91
2021-01-01 to 2021-03-310.01USD/shares90
2020-10-01 to 2020-12-31-0.06USD/shares92
2020-01-01 to 2020-12-31-0.22USD/shares366
2020-07-01 to 2020-09-30-0.03USD/shares92
2020-04-01 to 2020-06-30-0.06USD/shares91
2020-01-01 to 2020-03-31-0.07USD/shares91
2019-01-01 to 2019-12-31-0.23USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-01-01 to 2021-12-3134,891USD365
2020-01-01 to 2020-12-3155,902USD366
2019-01-01 to 2019-12-31-79,316USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-12-31442,635USD
At 2020-12-31574,169USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-12-31741,867USD365
2020-01-01 to 2020-12-311,046,516USD366
2019-01-01 to 2019-12-311,485,898USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-4,353,996USD92
2021-01-01 to 2021-12-31-7,677,420USD365
2021-07-01 to 2021-09-30-1,563,395USD92
2021-04-01 to 2021-06-30-1,435,729USD91
2021-01-01 to 2021-03-31-324,300USD90
2020-10-01 to 2020-12-31-1,745,946USD92
2020-01-01 to 2020-12-31-6,381,595USD366
2020-07-01 to 2020-09-30-1,208,686USD92
2020-04-01 to 2020-06-30-1,580,962USD91
2020-01-01 to 2020-03-31-1,846,001USD91
2019-01-01 to 2019-12-31-9,288,182USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-12-3145,688,013USD
At 2020-12-3149,969,592USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-01-01 to 2021-12-3198,031USD365
2020-01-01 to 2020-12-31263,627USD366
2019-01-01 to 2019-12-31246,186USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-12-3119,278,960USD
At 2020-12-3125,667,446USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-12-319,640,980USD
At 2020-12-3113,396,286USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2021-12-31882,000USD
At 2020-12-31882,000USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-12-3123,954,475USD
At 2020-12-3128,118,316USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-12-316,877,346USD
At 2020-12-3112,377,713USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2021-01-01 to 2021-12-311,386,849USD365
2020-01-01 to 2020-12-311,851,526USD366
2019-01-01 to 2019-12-313,494,921USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-12-318,429,882USD
At 2020-12-3110,638,157USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-01-01 to 2021-12-315,684,465USD365
2020-01-01 to 2020-12-315,773,825USD366
2019-01-01 to 2019-12-316,868,480USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-12-3114,742,754shares
At 2020-12-3114,988,429shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2021-12-3127,040,816USD
At 2020-12-3124,753,796USD
At 2019-12-3128,212,635USD
At 2018-12-3127,938,960USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2021-12-3142,601,978USD
At 2020-12-3146,873,394USD
At 2019-12-3151,085,253USD
At 2018-12-3155,570,501USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-12-311,024,200USD
At 2020-12-312,028,148USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-12-311,059,693USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-12-314,234,788USD
At 2020-12-314,131,256USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-12-313,792,153USD
At 2020-12-313,557,087USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-12-313,419,908USD
At 2020-12-313,234,338USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-12-317,488,844USD
At 2020-12-317,862,772USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-12-318,668,303USD
At 2020-12-3111,254,381USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-12-313,339,969USD
At 2020-12-312,199,926USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-5,562,230USD365
2020-01-01 to 2020-12-31-6,569,877USD366
2019-01-01 to 2019-12-31-9,291,004USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-3,602,799USD365
2020-01-01 to 2020-12-31-3,418,904USD366
2019-01-01 to 2019-12-31-3,546,511USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-01-01 to 2021-12-319,780,026USD365
2020-01-01 to 2020-12-3110,196,299USD366
2019-01-01 to 2019-12-319,974,384USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-12-314,606,366USD365
2020-01-01 to 2020-12-314,748,565USD366
2019-01-01 to 2019-12-314,404,175USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-01-01 to 2021-12-314,371,300USD365
2020-01-01 to 2020-12-314,434,120USD366
2019-01-01 to 2019-12-314,134,557USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-34,891USD365
2020-01-01 to 2020-12-3134,100USD366
2019-01-01 to 2019-12-31-144,724USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2020-01-01 to 2020-12-3121,802USD366
2019-01-01 to 2019-12-3165,408USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-12-3163,978USD365
2020-01-01 to 2020-12-31215,991USD366
2019-01-01 to 2019-12-31198,661USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-327USD365
2020-01-01 to 2020-12-31-91,486USD366
2019-01-01 to 2019-12-3116,694USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-5,500,367USD365
2020-01-01 to 2020-12-314,518,707USD366
2019-01-01 to 2019-12-311,399,012USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-4,816,450USD365
2020-01-01 to 2020-12-31-2,131,347USD366
2019-01-01 to 2019-12-31-1,106,175USD365

Inspect the source

Entity
Cumberland Pharmaceuticals Inc. / CIK 0001087294
Captured
2026-09-20T05:21:29.619Z
SEC response SHA-256
b37ed2fef35db1cde0c40b2233eb97cf370fc96d41a5c7d61b6a5a76a296e4a0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001087294.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))